UK markets open in 7 hours 7 minutes

Ocumension Therapeutics (1477.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
7.300+0.150 (+2.10%)
At close: 04:08PM HKT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
246,367
246,367
158,957
56,146
13,096
Cost of revenue
102,002
102,002
56,041
19,211
1,724
Gross profit
144,365
144,365
102,916
36,935
11,372
Operating expenses
Research development
123,768
123,768
184,309
169,055
179,550
Selling general and administrative
279,005
279,005
230,188
253,806
324,667
Total operating expenses
545,705
545,705
551,141
422,479
499,197
Operating income or loss
-401,340
-401,340
-448,225
-385,544
-487,825
Interest expense
1,325
1,325
1,793
567
59
Income before tax
-379,480
-379,480
-402,229
-259,992
-2,264,866
Income tax expense
0
307
414
0
-
Income from continuing operations
-379,787
-379,787
-402,643
-259,992
-2,264,866
Net income
-379,787
-379,787
-402,643
-259,992
-2,264,866
Net income available to common shareholders
-379,787
-379,787
-402,643
-259,992
-2,264,866
Basic EPS
-0.65
-0.59
-0.64
-0.43
-7.00
Diluted EPS
-0.65
-0.59
-0.64
-0.43
-7.00
Basic average shares
642,082
643,707
632,532
607,144
302,349
Diluted average shares
642,082
643,707
632,532
607,144
302,349